Form 4: Credo Technology Group Director Tan Lip Bu Sells Shares in Multiple Transactions

Sentiment:

SEC Form 4 Filing


Director Tan Lip Bu of Credo Technology Group Holding Ltd. reports selling shares in multiple transactions between October 11 and October 15, 2024.

Summary

  • Tan Lip Bu, a director of Credo Technology Group Holding Ltd, filed a Form 4 detailing changes in beneficial ownership.
  • On October 11, 2024, Tan Lip Bu sold 100,000 ordinary shares at a weighted average price of $38.156 per share.
  • On October 14, 2024, he sold 15,281 ordinary shares at a weighted average price of $39.055 per share.
  • On October 15, 2024, he sold 34,719 ordinary shares at a weighted average price of $37.2895 per share.
  • Following these transactions, Tan Lip Bu indirectly owns 1,713,725 ordinary shares through Walden Technology Ventures Investments II, L.P.
  • He also indirectly owns 133,583 shares through the Lip-Bu Tan and Ysa Loo Trust, and 39,736 shares through A&E Investment LLC.
  • Tan Lip Bu directly owns 49,166 ordinary shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock sales by a company director. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock sales by a company insider. It's common for directors and officers to periodically sell shares for personal financial management.

Key Dates

DateDescription
02/03/1992Date of the Lip-Bu Tan and Ysa Loo Trust
10/11/2024Sale of 100,000 ordinary shares
10/14/2024Sale of 15,281 ordinary shares
10/15/2024Sale of 34,719 ordinary shares and filing date of the Form 4

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.